CNNMoney.com
Companies Economy International Corrections Pre-market Trading After-hours Trading Winners/Losers/Actives Bonds Currencies Commodities World Markets Money Magazine Real Estate Taxes Jobs Ask the Expert Money 101 Autos Mutual Funds The Help Desk Loan Center Best Places to Live Ask the Expert Ultimate Guide to Retirement Retirement Calculators Best Funds Best Places to Retire Fortune Brainstorm Tech Apple 2.0 Blog Big Tech Blog Sectors and Stocks Tech Talk Resource Guide Small Business Makeovers Questions & Answers Small Business Video 100 Best Places to Launch FSB 100 Fortune Small Business Fortune 500 Brainstorm Tech Investing Management C-Suite Rankings Main Create Portfolio Edit Portfolio Create Alerts Edit Alerts

Antidepressants may not work - report

Antidepressant drugs may have little effect on patients, many unpublished studies show.

Subscribe to Companies
google my aol my msn my yahoo! netvibes
Paste this link into your favorite RSS desktop reader
See all CNNMoney.com RSS FEEDS (close)

drug_bottles.03.jpg
Anti-depressants may not be as effective as patients -- and doctors -- believe.

NEW YORK (CNNMoney.com) -- Patients and doctors alike may have received some fuzzy truth about the effectiveness of antidepressant medication.

According to a report in The Wall Street Journal, many studies have found that best-selling antidepressants like Wyeth's Effexor and Pfizer's Zoloft may have little or even no effect on patients. Many of those studies, though submitted to the Food and Drug Administration, were left unpublished.

Researchers accordingly suggested in this week's New England Journal of Medicine that doctors and patients may not have been able to see the full antidepressant picture.

Both Pfizer (PFE, Fortune 500) and Wyeth (WYE, Fortune 500) told The Wall Street Journal that they will disclose all study results, but they will not necessarily publish them in medical journals. The FDA does not require pharmaceutical companies to publish the studies that they sponsor, which leaves many studies unpublished.

Separately, 74 studies involving 12 antidepressant drugs were submitted to the FDA between 1987 and 2004, 38 of which the FDA called "positive." Though all but one of the "positive" studies were published, only 14 of the 36 "negative" studies were printed in medical journals.

But even with the large disparity of reports that the pharmaceutical companies published, not all of the negative stories were all that "negative."

According to the NEJM researchers, at least 11 of the 14 "negative" studies presented unfavorable findings as beneficial ones by highlighting positive secondary outcomes and ignoring negative primary results.

The New England Journal of Medicine researchers believe this "publication bias" can complicate doctors' understanding of the effectiveness of medications. For instance, when considering all of the studies' data, the researchers found that Zoloft only has a "small" effect on patients as opposed to the "medium" effect that the mostly-positive results had shown.  To top of page

Photo Galleries
Holiday gifts for the yoga nut These 7 small brands are helping fuel a booming yoga industry. More
Best of the L.A. Auto Show Fuel economy is the name of the game in Southern California. More
Are things really getting better? Last quarter, the economy grew by the largest amount since the summer of 2007, but there are signs that things are still getting worse. More
Sponsors
© 2009 Cable News Network. A Time Warner Company. All Rights Reserved. Terms under which this service is provided to you. Privacy Policy
Copyright © 2009 BigCharts.com Inc. All rights reserved. Please see our Terms of Use.
MarketWatch, the MarketWatch logo, and BigCharts are registered trademarks of MarketWatch, Inc.
Intraday data provided by Interactive Data Real-Time Services and subject to the Terms of Use.
Intraday data is at least 20-minutes delayed. All times are ET.
Historical, current end-of-day data, and splits data provided by Interactive Data Pricing and Reference Data.
Fundamental data provided by Morningstar, Inc..
SEC Filings data provided by Edgar Online Inc..
Earnings data provided by FactSet CallStreet, LLC.